Husseini K. Manji, MD, FRCPC: Impairments of Neuroplasticity and Cellular Resilience in Severe Mood Disorders: Implications for the Development of Novel Therapeutics

Name: Husseini K. Manji, MD, FRCPC: Impairments of Neuroplasticity and Cellular Resilience in Severe Mood Disorders: Implications for the Development of Novel Therapeutics
SKU: 3342
Price: 30.00 USD
Availability: InStock

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 35 No. 2 Articles Tags: cellular-resilience, husseini-k-manji, medworks-media, mood-disorders, neuroplasticity, psychopharmacology-bulletin, ronald-s-duman

Description

Husseini K. Manji, MD, FRCPC: Impairments of Neuroplasticity and Cellular Resilience in Severe Mood Disorders: Implications for the Development of Novel Therapeutics

Description

Husseini K. Manji, MD, FRCPC

TRANSLATIONAL NEUROSCIENCE

Impairments of Neuroplasticity and Cellular Resilience in Severe Mood Disorders: Implications for the Development of Novel Therapeutics

Husseini K. Manji,MD, FRCPC and Ronald S. Duman, PhD

Paliperidone Double-blind, Placebo- and Active-Controlled, Study

Assessment of Anxiety in Clinical Trials with Depressed Patients

Zonisamide for Bipolar Disorder, Mania or Mixed States by Deborah Dauphinais

Vilazodone – Safety and Tolerability Profile PB VOL 44 No. 3

Husseini K. Manji, MD, FRCPC: Impairments of Neuroplasticity and Cellular Resilience in Severe Mood Disorders: Implications for the Development of Novel Therapeutics

Description

Husseini K. Manji, MD, FRCPC

TRANSLATIONAL NEUROSCIENCE

Impairments of Neuroplasticity and Cellular Resilience in Severe Mood Disorders: Implications for the Development of Novel Therapeutics

Husseini K. Manji,MD, FRCPC and Ronald S. Duman, PhD

Related products

Paliperidone Double-blind, Placebo- and Active-Controlled, Study

Assessment of Anxiety in Clinical Trials with Depressed Patients

Zonisamide for Bipolar Disorder, Mania or Mixed States by Deborah Dauphinais

Vilazodone – Safety and Tolerability Profile PB VOL 44 No. 3